// App-Quantinova.ai

794 : Venous thromboembolism and adverse outcomes in highest-VTE risk gravidas compared to those at lower risk

Researchers

Presenter

  • Margaret R. Page

Principal Investigators

  • Christina T. Blanchard

  • Michelle Y. Lu

  • Akila Subramaniam

  • Kacie R. Oglesby

  • Elizabeth B. Ausbeck

  • Gabriella D. Cozzi

  • Rodrigo Munoz Rogers

  • Elisa T. Bushman

  • Elle R. Kaplan

  • Martha F. Ruzic

  • Mythreyi Mahalingam

  • Sarah A. Dunk

  • Macie L. Champion

  • Dhong-Jin Kim

  • Jeff M. Szychowski

  • Alan Tita

  • Brian M. Casey

Medical Centers

  • Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL,

  • Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL,

  • Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL,

  • University of Alabama at Birmingham, Birmingham, AL

  • University of North Carolina Obstetrics and Gynecology, Chapel Hill, NC

  • Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL,

  • School of Medicine, University of Alabama at Birmingham, Birmingham, AL.

  • Resident PhysicianUniversity of Alabama at BirminghamBirmingham, AL

  • Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Hematoma

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved